期刊文献+

子宫内膜癌患者血雌激素水平与预后的关系探讨 被引量:2

Study on Estrogen Levels and Prognosis in Patients with Endometrial Carcinoma
下载PDF
导出
摘要 目的 :探讨雌激素水平与子宫内膜癌的关系。方法 :对 92例绝经后子宫内膜癌的雌激素水平及其临床病理资料进行回顾性分析。结果 :92例患者中 ,高雌激素水平 (术前血浆雌二醇 >385pmol/L ,平均值 12 4 6 .9± 119.4 pmol/L) 58例 (6 3.0 4 % ) ,雌激素水平在正常范围 (术前血浆雌二醇 <385pmol/L ,平均值 192 .8± 12 8.9pmol/L) 34例 (36 .96 % ) ;前者伴发肥胖、高血压、糖尿病明显高于后者 (P <0 .0 5) ,且前者临床期别早 ,组织学改变以子宫内膜增生常见 (P <0 .0 5) ,细胞分化好 ,肌层浸润及宫颈转移前者显著低于后者 (P <0 .0 5) ;5年生存率前者 91.38% ,后者 73.53% ,二者有显著差异 (P <0 .0 5)。结论 :子宫内膜癌存在两种类型 ,Ⅰ型为雌激素相关型 ,Ⅱ型为非雌激素相关型。 Objective:To investigate the relationship between estrogen and endometrial carcinoma.Methods:In a retrospective study,the estrogen level and the clinical and pathological data from 92 patients with endometrial carcinoma were analyzed. Results:It was shown that the estrogen level increased in 58 cases (63.04%) (Group A)(1246.9±119.4pmol/L) and was normal in 34 cases (36.96%) (Group B)(192.8±128.9pmol/L). The prevelance rates of obesity,hypertension and diabetes were higher in patients with increased estrogen (P<0.05). Most of the cases with higher estrogen were at the earlier stage of the cancer,and endometrical hyperplasia was the common histological change(P<0.05). Muscular infiltration and servical metastasis of the cancer was significantly lower in group A than that in group B (P<0.05). 5-year survival rate was 91.38% and 73.53% in group A and B respectively,and the difference was significant(P<0.05). Conclusion:There are two types of endometrial carcinoma ,type one is correlated with estrogen,with the better prognosis.
作者 陈梅 金毓翠
出处 《广州医学院学报》 2000年第4期24-27,共4页 Academic Journal of Guangzhou Medical College
关键词 子宫内膜癌 雌激素 预后 病理 endometrial carcinoma estrogen.
  • 相关文献

参考文献6

二级参考文献2

  • 1曹泽毅,中华妇产科学,1999年,1844页
  • 2Chuang L,Gynecol Oncol,1995年,58期,189页

共引文献76

同被引文献26

  • 1陈业希,洪壁楷,黄楚锦,陈维荣,蔡高阳,吴成亮,蔡道全.三苯氧胺治疗乳腺增生病不同疗程血清性激素水平的变化[J].汕头大学医学院学报,2006,19(3):175-177. 被引量:2
  • 2DANSER A H, DERKX F H, SCHALEKAMP M A,et al. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro) renin levels in humans [J]. J Hypertens, 1998, 16 (6) : 853.
  • 3HARRISON- BERNARD L M, RAU L . Postmenopausal hypertension [J] . Curr Hypertons Rep,2000, 2 (2): 202.
  • 4W A SSERTHEIL SMOLLER S, ANDERSON G,PSATY B M, et al . Hypertension and its treatment in postmenopausal women : baseline date from the women' s health initiative [ J ] Hypertension,2000, 36 (5) : 780.
  • 5MODENA M G, RO68I R, MUIA N J R, et al.Short- term results of transdermal estrogen replacement therapy in cardiovascular disease - free postmenopausal females with and without hypertension[J]. G Ital Gardiol, 1998, 28 (6) : 634.
  • 6DUCAILARG, RIBSTEIN J, PASO3qIEJ L, et al. Determinant of left Ventricular hypertrophy in the hypertensive women, influence of hermone replacemerit therapy for menopause Inflnuence of hermone replacemevit therapy for menopause [J]. Arch Mal Coear Vaiss, 1999, 92 (8): 975.
  • 7AMEOROSO A, GARZIA P, FERRI G M, et al.Hypertension and menopausal syndrome: of hormone replacement therapy and antihypertonsive drugs [J].Riv Eur Sci Med Farmacol, 1996, 18 (4) : 149.
  • 8AGABITII ROSEI E, AMBROSIONI E, PIRELLI A, et al. Efficacy and tolerability of moexipril and nitrendipine in postmenopausal women with hypertension, MADAM. study group moexipril as antihypertensine drug after menopause [J]. Eur J Clin Pharmacol, 1999, 55 (3) - 185.
  • 9KOCH B, OPARIL S, SLIMPEL M. Co- administration of an ACE - inhibitor (rmexipril) and hormonal replacement therapy in postmenopausal women[J]. J Hum Hypertens, 1999, 13 (5): 337.
  • 10GROHE C, KAHI.KRT S, LOBBERT K, et al .Angiotensin converting enzyme inhibition modulatescardiac fibroblast growth [J] . J Hypertens, 1998,16 (3) : 377.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部